GlobalData
GlobalData

Medical Devices

Pipeline in vitro diagnostic products for coronavirus shifts towards point of care and rapid diagnostics

The coronavirus (COVID-19) pandemic has had a dramatic impact on the in vitro diagnostics (IVD) testing market resulting in reagent shortages, new product launches and a host of new pipeline products entering development, says GlobalData, a leading data and analytics company. The current test used to diagnose COVID-19 is an RT-PCR based assay. In recent months, the pandemic has led to overwhelming demands for RT-PCR reagents causing shortages in reagents required for key steps in the testing process, such as RNA extraction kits. Companies […]
Read more

With Mylab Covid-19 test kits approval India looks to expand testing criteria, says GlobalData

Following the news that molecular diagnostic company Mylab has received approval for its Covid-19 diagnostic test kits from the Drug Controller General of India (DCGI); Rohit Anand, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “India so far has followed a restrictive testing protocol for suspected Covid-19 cases and […]
Read more

India needs to step up production of personal protective equipment to avert supply disruptions amid Covid-19 outbreak, says GlobalData

Anticipating increased demand for personal protective equipment (PPE) products following the rising number of coronavirus (Covid-19) cases, India has recently decided to ban their exports. However, as the entire world is battling the coronavirus outbreak, India needs to speed up domestic production to avert any medical equipment supply chain disruption, says GlobalData, a leading data […]
Read more

Non-invasive prenatal testing is expected to total $472.2m by 2028, disrupting the prenatal screening market

The global market value for non-invasive prenatal testing (NIPT), estimated at USD$433.7m in 2019, is expected to increase at a Compound Annual Growth Rate (CAGR) of 0.95%, reaching USD$472.2 by 2028. This increase is driven through the procedures greater safety, sensitivity, and continued adoption within key markets, says GlobalData, a leading data and analytics company. The company’s latest report, ‘Prenatal Screening – In Vitro Diagnostics Market Analysis and Forecast Model’, reveals that the vast majority of women preferred NIPT, compared to chorionic villus sampling […]
Read more

With Roche Diagnostics coronavirus test approval India looks to delay progression to next stage, says GlobalData

Following the news that the the Drug Controller General of India (DCGI) has given license to Roche Diagnostics India to conduct coronavirus tests; Rohit Anand, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “Coronavirus (Covid-19) outbreak has squeezed the imports and countries across the world are rushing to secure […]
Read more

Thermo Fisher to be key player in COVID-19 diagnostic tests following acquisition of Qiagen

Thermo Fisher Scientific is expected to produce millions of coronavirus (COVID-19) diagnostic tests following the acquisition of Qiagen for an approximate transaction value of US$11.5bn per share, says GlobalData, a leading data and analytics company. Qiagen, a provider of molecular diagnostics and sample preparation technologies, offers a long list of nucleic acid amplification tests (NAATs) […]
Read more

ACC’s virtual scientific session may limit impact of COVID-19 pandemic on cardiovascular research and market

Following the cancelation of the 2020 Scientific Session due to the coronavirus (COVID-19), the American College of Cardiology (ACC) has created a virtual three-day scientific session in order to minimize any impact to the advancement of cardiology research. However, this may limit the impact of the COVD-19 pandemic on cardiovascular research, says GlobalData, a leading […]
Read more

Global capsule endoscopes market set to reach $401.4m by 2028

The global capsule endoscopes market is expected to reach $401.4m by 2028, growing at a compound annual growth rate (CAGR) of 4.2%, according to GlobalData, a leading data and analytics company. The company’s recent report, ‘Capsule Endoscopes – Medical Devices Pipeline Assessment, 2020’, reveals that the Asia Pacific region will be one of the fastest growing […]
Read more

US percutaneous ventricular assist device market expected to grow at a CAGR of 11.6% by 2028, says GlobalData

There are more than 160,000 patients undergoing percutaneous coronary interventions to treat cardiogenic shock each year, yet only just fewer than 5,000 are currently treated with a percutaneous ventricular assist device (PVAD), according to GlobalData, a leading data and analytics company. Ashley Young, Medical Devices Analyst at GlobalData, comments: “PVADs are gaining increased attention due […]
Read more

Phased manufacturing program will open opportunities for domestic and foreign medical device makers in India, says GlobalData

India’s plan to initiate a phased manufacturing program (PMP) to reduce import dependency will open opportunities to domestic and foreign medical device manufacturers in India, says GlobalData, a leading data and analytics company. The company’s report, ‘X-Ray Systems – Diagnostic Imaging Market Analysis and Forecast Model’ reveals that the Indian X-Ray systems market, which accounted […]
Read more
1 47 48 49 50 51